Form 4: Stryker Group President Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Stryker Group President Viju Menon reported the sale of 500 shares of common stock for $390.61 per share under a pre-arranged trading plan.
Summary
- Viju Menon, Group President of Stryker Corp, sold 500 shares of common stock.
- The transaction occurred on August 25, 2025, at a price of $390.61 per share.
- Following the sale, Menon directly owns 12,511 shares and indirectly owns 197 shares through a 401K.
- The sale was executed under a Rule 10b5-1 pre-arranged trading plan, indicating it was a scheduled transaction.
Sentiment
Score: 5
Explanation: Neutral. A routine insider sale under a pre-arranged 10b5-1 plan is generally not indicative of strong positive or negative sentiment regarding the company's future prospects. It's a planned liquidity event for the insider.
Future Outlook
No forward-looking statements or guidance were provided.
Industry Context
This insider transaction report does not provide specific industry context or analysis of broader industry trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Attorney-in-Fact | Viju S. Menon granted power of attorney to several individuals (Austin Y. Ke, Jessica R. Kennedy, Jessica M. Herron, Garrett Packer, and Stephanie M. Swan) to handle SEC filings and EDGAR account administration on his behalf. | 08/20/2025 | Streamlines compliance for insider reporting requirements for Viju S. Menon, ensuring timely and accurate filings with the SEC. |
Stakeholder Impact
- Shareholders: May observe an insider sale, which could be interpreted in various ways, though a 10b5-1 plan suggests a pre-planned, non-discretionary transaction for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 08/20/2025 | Execution date of Power of Attorney by Viju S. Menon, authorizing attorneys-in-fact to handle SEC filings. |
| 08/25/2025 | Date of common stock transaction, involving the sale of 500 shares. |
| 08/27/2025 | Date Form 4 was signed by the attorney-in-fact, Austin Y. Ke. |
Recommendation
holdThis filing is a routine Form 4 disclosing an insider sale under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter an existing investment thesis.
Keywords
Stryker Corp, SYK, Insider Trading, Form 4, Stock Sale, Viju Menon, Group President, 10b5-1 Plan, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.